Recent innovations in 3D-printed personalized medicines: an interview with Abdul Basit

Abdul Basit holds the position of Professor of Pharmaceutics at the UCL School of Pharmacy, University College London (UK). Basit is an internationally leading authority on oral drug delivery, digital health and innovative pharmaceutical technologies including 3D printing. Basit is a world authority on translational research; he has founded two spin-out companies (FabRx Ltd and Intract Pharma, both in London, UK) and has invented several drug products that have entered the clinic. More than a million patients to date have benefited from the treatments originating from his laboratory. Across his career, Basit has received prestigious awards from the American Association of Pharmaceutical Scientists, Academy of Pharmaceutical Sciences, GlaxoSmithKline and AstraZeneca and was listed among the world’s most highly influential researchers in 2019.